Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypertonic saline injection approaches for diabetic neuropathy
IRCT20170517034008N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of hypertonic saline in diabetic neuropathy (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Neuropathy assessment and Douleur Neuropathique 4 questionnaire score. Started Apr 2019; status: completed.
02
Drugs
hypertonic saline
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on IRCT20170517034008N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170517034008N1.